TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 45 filers reported holding TERNS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,801 | -42.5% | 3,539 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $30,966 | +1448.3% | 3,539 | +399.9% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 708 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -28.6% | 708 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | -22.2% | 708 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | -43.8% | 708 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $16,000 | – | 708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |